AI assistant
NEKTAR THERAPEUTICS — Director's Dealing 2016
Sep 19, 2016
32134_dirs_2016-09-19_dcc8348e-5f37-42f7-afbd-8548447977dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2016-09-15
Reporting Person: GREER R SCOTT (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-15 | Common Stock | M | 15000 | $0.00 | Acquired | 98333 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-15 | Restricted Stock Unit | $ | M | 15000 | Disposed | Common Stock (15000) | Direct |
Footnotes
F1: Represents restricted stock units ("RSU"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on September 15, 2015, vested in full one year following the grant date.
F2: The total holdings includes the 15,000 shares of restricted stock units ("RSUs") that were previously reported in Table II for the reporting person and which are being reclassified to Table I. These RSUs were granted on September 15, 2015, are convertible on a one-for-one basis into shares of Common Stock of the Company, and vested on September 15, 2016.